Michael E. Tarvin - 01 Aug 2023 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Aug 2023, 16:23:37 UTC
Prior SEC filing
31 Jul 2023
Next SEC filing
01 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael E. Tarvin

Key filing fact

Michael E. Tarvin filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 02 Aug 2023.

Key facts

  • This page summarizes Michael E. Tarvin's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Aug 2023, 16:23.

Change

  • Previous filing in this sequence was filed on 31 Jul 2023.
  • Current net transaction value: -$440,722.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SEM transaction

Common Stock

Tax liability

Transaction value
$440,722
Shares
-14,730
Change %
-4.2%
Price
$29.92
Shares after
337,365
Date
01 Aug 2023
Ownership
Direct
Footnotes
F1
SEM transaction

Common Stock

Award

Transaction value
$0
Shares
+100,000
Change %
+30%
Price
$0.000000
Shares after
437,365
Date
01 Aug 2023
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.

Footnote F2

Grant of restricted stock which will vest in equal annual installments over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .